121 related articles for article (PubMed ID: 9935145)
21. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
[TBL] [Abstract][Full Text] [Related]
22. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
Laukkanen P; Koskela P; Pukkala E; Dillner J; Läärä E; Knekt P; Lehtinen M
J Gen Virol; 2003 Aug; 84(Pt 8):2105-2109. PubMed ID: 12867641
[TBL] [Abstract][Full Text] [Related]
23. Stability over time of serum antibody levels to human papillomavirus type 16.
af Geijersstam V; Kibur M; Wang Z; Koskela P; Pukkala E; Schiller J; Lehtinen M; Dillner J
J Infect Dis; 1998 Jun; 177(6):1710-4. PubMed ID: 9607854
[TBL] [Abstract][Full Text] [Related]
24. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P
J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761
[TBL] [Abstract][Full Text] [Related]
25. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
[TBL] [Abstract][Full Text] [Related]
26. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
[TBL] [Abstract][Full Text] [Related]
27. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.
Touzé A; de Sanjosé S; Coursaget P; Almirall MR; Palacio V; Meijer CJ; Kornegay J; Bosch FX
J Clin Microbiol; 2001 Dec; 39(12):4344-8. PubMed ID: 11724843
[TBL] [Abstract][Full Text] [Related]
29. Papillomavirus capsids: a new approach to identify serological markers of HPV infection.
Galloway DA
J Natl Cancer Inst; 1994 Apr; 86(7):474-5. PubMed ID: 8133525
[No Abstract] [Full Text] [Related]
30. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
[TBL] [Abstract][Full Text] [Related]
31. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.
Andersson-Ellström A; Dillner J; Hagmar B; Schiller J; Sapp M; Forssman L; Milsom I
Sex Transm Dis; 1996; 23(3):234-8. PubMed ID: 8724515
[TBL] [Abstract][Full Text] [Related]
32. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
Wentzensen N; Rodriguez AC; Viscidi R; Herrero R; Hildesheim A; Ghosh A; Morales J; Wacholder S; Guillen D; Alfaro M; Safaeian M; Burk RD; Schiffman M
J Infect Dis; 2011 Jul; 204(1):94-102. PubMed ID: 21628663
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of human papillomavirus antibodies in young female subjects in England.
Jit M; Vyse A; Borrow R; Pebody R; Soldan K; Miller E
Br J Cancer; 2007 Oct; 97(7):989-91. PubMed ID: 17726462
[TBL] [Abstract][Full Text] [Related]
35. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
36. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
[TBL] [Abstract][Full Text] [Related]
37. [Antibody toward human papillomavirus type 16 (HPV16) L1-capsids].
Matsumoto K; Yoshikawa H
Nihon Rinsho; 1999 Nov; 57 Suppl():282-5. PubMed ID: 10635835
[No Abstract] [Full Text] [Related]
38. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
39. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
Simen-Kapeu A; Kataja V; Yliskoski M; Syrjänen K; Dillner J; Koskela P; Paavonen J; Lehtinen M
Scand J Infect Dis; 2008; 40(9):745-51. PubMed ID: 19086247
[TBL] [Abstract][Full Text] [Related]
40. A seroepidemiologic study of HPV infection and incident cervical squamous intraepithelial lesions.
Strickler HD; Dillner J; Schiffman MH; Eklund C; Glass AG; Greer C; Scott DR; Sherman ME; Kurman RJ; Manos M
Viral Immunol; 1994; 7(4):169-77. PubMed ID: 7576031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
